Immune Regulation News Volume 2.14 | Apr 23 2010

    By
    Justin.choi
    -
    0
    62

    Immune Regulation News 2.14, April 23, 2010.
    In this issue: Science News  |  Current Publications  |  Industry News  |  Policy News  |  EventsSubscribe  |  Unsubscribe


    TOP STORY

    How Genetic Mutations May Cause Type 1 Diabetes: Findings Point to New Drug Target
    Scientists from The Scripps Research Institute have provided an answer to the 40-year-old mystery of how certain genetic mutations lead to Type 1 diabetes. This new molecular understanding could lead to novel therapies for Type 1 diabetes and other autoimmune diseases. [Press release from ScienceDaily discussing online prepublication in Journal of Clinical Investigation]

    Request A Poster 
    Isolate Untouched Cells for
    Antigen Processing and Presentation
    with EasySep®
    		 
     
    REQUEST A POSTERSTEMCELL Technologies Inc
    		 

    SPECIAL FEATURE

    Video – RosetteSep® – Cell Separation with a Simple Spin

    SCIENCE NEWS

    Carbon Nanotubes Boost Cancer-Fighting Cells
    Yale University engineers have found that the defects in carbon nanotubes cause T cell antigens to cluster in the blood and stimulate the body’s natural immune response. [Press release from Yale University discussing online prepublication in Langmuir]

    Researchers Identify the Source of ‘Noise’ In HIV
    New research identifies a molecular mechanism that the human immunodeficiency virus (HIV) appears to utilize for generating random fluctuations called “noise” in its gene expression. [Press release from EurekAlert! discussing online prepublication in Biophysical Journal]

    RoboSep_645x110_v02 

    CURRENT PUBLICATIONS

    Lethal Graft-Versus-Host Disease in Mouse Models of T Cell Receptor Gene Therapy
    Researchers show that the pairing of introduced and endogenous T cell receptor (TCR) chains in TCR gene-modified T cells leads to the formation of self-reactive TCRs that are responsible for the observed autoimmunity. [Nat Med]

    Indirect Inhibition of Toll-like Receptor and Type I Interferon Responses by ITAM-Coupled Receptors and Integrins
    These results provide an indirect mechanism of cross-inhibition of Toll-like receptors and delineate a signaling pathway important for deactivation of macrophages. [Immunity]

    E-Cadherin Marks a Subset of Inflammatory Dendritic Cells that Promote T Cell-Mediated Colitis
    Here, researchers show that monocyte-derived inflammatory dendritic cells that express E-cadherin, the receptor for CD103, promote intestinal inflammation. [Immunity]

    Reversal of Autoimmunity by Boosting Memory-like Autoregulatory T Cells
    Researchers show that progression to autoimmune diabetes results in the conversion of naive low-avidity autoreactive CD8+ T cells into memory-like autoregulatory cells that can be expanded in vivo with nanoparticles coated with disease-relevant peptide-major histocompatibility complexes. [Immunity]

    The Diabetogenic Mouse MHC Class II Molecule I-Ag7 is Endowed with a Switch that Modulates TCR Affinity
    The results support the existence of a switch at residue beta57 of the I-Ag7 and HLA-DQ8 class II molecules and potentially link normal thymic T cell receptor selection with abnormal peripheral behavior. [J Clin Invest]

    Altered Regulatory T Cell Homeostasis in Patients with CD4+ Lymphopenia Following Allogeneic Hematopoietic Stem Cell Transplantation
    Here, researchers analyzed reconstitution of regulatory T cells and conventional CD4+ T cells in patients who underwent allogeneic hematopoietic stem cell transplantation after myeloablative conditioning. [J Clin Invest]

    Elevated IL-17 Produced by TH17 Cells Promotes Myeloma Cell Growth and Inhibits Immune Function in Multiple Myeloma
    As IL-6 and TGF-beta are important for the generation of TH17 cells, researchers observed a significantly elevated baseline and induced frequency of TH17 cells in peripheral blood and bone marrow mononuclear cells from multiple myeloma patients compared to healthy donors. [Blood]

    Allergic Conjunctivitis Exacerbates Corneal Allograft Rejection by Activating Th1 and Th2 Alloimmune Responses
    Because allergic conjunctivitis and airway hyperreactivity are allergic diseases of mucosal tissues, researchers determined whether an allergic disease of a nonmucosal tissue would affect corneal allograft rejection and whether Th2 cells alone accounted for accelerated graft rejection in allergic mice. [J Immunol]

    Transcriptional Bursting from the HIV-1 Promoter is a Significant Source of Stochastic Noise in HIV-1 Gene Expression
    To probe the regulatory mechanisms controlling expression of HIV-1, researchers analyze noise in gene-expression from HIV-1’s long terminal repeat promoter at different HIV-1 integration sites across the human genome. [Biophys J]

    INDUSTRY NEWS

    New Preclinical Breast Cancer Study Shows Peregrine’s PS-Targeting Antibodies Can Reverse Tumor-Induced Immune Suppression
    Peregrine Pharmaceuticals, Inc. reported data from a new preclinical study demonstrating that the company’s phosphatidylserine (PS)-targeting antibodies reversed immune suppression by tumors and conferred tumor-specific immunity in models of breast cancer. [Peregrine Pharmaceuticals, Inc. Press Release]

    Abbott Successfully Completes Tender Offer for Shares of Facet Biotech
    Abbott today announced the successful completion of the tender offer by its wholly owned subsidiary Amber Acquisition Inc. to purchase all of the outstanding shares of common stock of Facet Biotech. [Abbott Laboratories Inc. Press Release]

    HGSI, GlaxoSmithKline say Lupus Drug Benlysta Worked for a Year but Didn’t Meet Long-Term Goal
    Human Genome Sciences Inc. and GlaxoSmithKline PLC reported a setback as study data showed their lupus drug, Benlysta, worked no better than standard treatment after a year and a half. [The San Francisco Examiner]

    POLICY NEWS

    Patents Block Competition, Slow Innovation in Gene Testing
    Exclusive licenses to gene patents, most of which are held by academic institutions and based on taxpayer-funded research, do more to block competition in the gene testing market than to spur the development of new technologies for gauging disease risk. [Duke University Press Release]

    Policy Reminder Concerning Appendix Materials for All National Institutes of Health/Agency for Healthcare Research and Quality/National Institute for Occupational Safety and Health Grant Applications (NOT-OD-10-077) [National Institutes of Health, United States]

    Enhancing Peer Review: Clarification of Resubmission Policy and Determination of New Application Status (NOT-OD-10-080) [National Institutes of Health, United States]

    Guidance on Confirming Appropriate Charges to NIH Awards During Periods of Noncompliance for Activities Involving Animals (NOT-OD-10-081) [National Institutes of Health, United States]

    Update of Sample Animal Welfare Assurance for Foreign Institutions (NOT-OD-10-083) [National Institutes of Health, United States]

    Agency for Healthcare Research and Quality Small Research Grant Program (R03) (PAR-10-168) [National Institutes of Health, United States]

    EVENTS

    97th Annual Meeting of the American Association of Immunologists (AAI)
    May 7-11, 2010
    Baltimore, United States

    29th Congress of the European Academy of Allergy and Clinical Immunology (EAACI)
    June 5-9, 2010
    London, United Kingdom

    Keystone Symposia: Innate Immunity – Mechanisms Linking with Adaptive Immunity (D3)
    June 7-12, 2010
    Dublin, Ireland

    Federation of Clinical Immunology Societies (FOCIS) 2010
    June 24-27, 2010
    Boston, United States

    Frontiers in Immunology Research (FIRN) 2010 International Conference
    July 22-26, 2010
    Athens, Greece

    14th International Congress of Immunology
    August 22-27, 2010
    Kobe, Japan

    Select BioSciences 7th Annual RNAi & miRNA Europe
    September 14-15, 2010
    Dublin, Ireland

    5th International Conference on Gene Regulation in Lymphocyte Development
    October 9-14, 2010
    Chania, Greece

    Autumn Immunology Conference 2010
    November 19-22, 2010
    Chicago, United States

    Cell Symposia, Influenza: Translating Basic Insights
    2-4 December 2010
    Washington D.C., United States

    Visit our events page  to stay up to date with the latest events in the cell, gene and immunotherapy community.


    JOB OPPORTUNITIES

    Sr. Product Support and Training Specialist (CardianBCT)

    Recruit Top Talent
    Reach more than 11,000 potential candidates by posting your organization’s career opportunities with Cell Therapy News.

    Visit      here to post your career opportunities.


    Have we missed an important article or publication in Immune Regulation News? Click here to submit!


    Learn more about Immune Regulation News: Archives  |  Events  |  Subscribe  |  Contact Us